國美系全線大漲 新聞聯播報道國美援建方艙行動 市場再炒黃光裕出獄
格隆匯2月14日丨港A兩市國美系股票全線大漲,港股市場國美零售(0493.HK)半日收漲13.25%,最高報0.97港元創2年新高,國美金融科技(0628.HK)漲9.68%;A股市場國美通訊(600898.SH)漲5.6%,中關村(000931.SZ)漲4%。昨晚央視新聞聯播報道國美援建方艙行動,稱國美集團積極落實“應收盡收”號召,馳援多家方艙醫院,發揮大連鎖優勢,高效協同,再現“中國速度”。值得注意的是,黃光裕原定2021年2月16日出獄,還剩1年零兩天。據悉,刑期過半即可申請假釋,而且理論上還有一次減刑機會,此外年滿50歲(出生於1969年)申請保外就醫也有一定成功概率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.